Troxerutin, capsules 300 mg 50 pcs

Troxerutin – venotonizing, angioprotective agent, bioflavonoid. It reduces capillary permeability and fragility, strengthens the vascular wall, improves microcirculation, has an anti-edema effect. Participates in the redox processes, blocks the hyaluronic acid of the cell membranes. < br>

increases the density of the vascular wall, reduces the exudation of the liquid part of the plasma and diapedesis of blood cells. Reduces inflammation in the vascular wall by limiting platelet adhesion to its surface.

The use of Troxerutin is possible both in the initial and in the later stages of the treatment of chronic venous insufficiency, it is possible to use as one of the components of complex treatment.

Pharmacokinetics

After oral administration the drug is absorbed from the gastrointestinal tract, Cmax in plasma is noted on average 2 hours after administration, therapeutic plasma levels are maintained for 8 hours.

Metabolized in the liver, partially excreted unchanged in the urine and bile.

< br>.

Indications

Vascular lesions in diabetes, Thrombophlebitis, Varicose veins, Trophic ulcers, Edema, Stiffness and pain in the legs, Pain, Hemorrhoids, Hematomas

• chronic venous insufficiency;
• trophic disorders in chronic venous insufficiency (dermatitis, trophic ulcers);
• varicose dilated veins;
• surface thrombophlebitis, periphlebitis;
• postthrombotic syndrome;
• posttraumatic edema, hematomas;
• hemorrhoids;
• diabetic angiopathy, retinopathy.

.

Active ingredient

Troxerutin

Composition

1 capsule contains:

the active ingredient:

troxerutin 300 mg

How to take, the dosage

Troxerutin capsules should be swallowed whole with meals. Usually prescribes 1 capsule 3 times a day orally, as a maintenance therapy – 1 capsule 2 times a day. The average course of treatment is 3-4 weeks, the need for longer treatment is determined individually.

Interaction

When used simultaneously, it increases the effect of ascorbic acid on the structure and permeability of the vascular wall.

.

Special Instructions

There is no experience of using the drug in children under 15 years of age.

In the treatment of superficial thrombophlebitis or deep vein thrombosis, the use of Troxerutin Zentiva does not exclude the need for anti-inflammatory and antithrombotic therapy.

Impact on driving and operating machinery

The use of Troxerutin Zentiva has no effect on motor and mental reactions and does not hinder driving and operating machinery.

.

Contraindications

• gastric and duodenal ulcer, chronic gastritis (acute phase);
• high sensitivity to the drug.

With caution: the drug should be used (prolonged use) in renal failure.

.

Side effects

Headache, irritation of the gastrointestinal mucosa, allergic reactions in the form of skin rashes and itching.

.

Overdose

In case of overdose, the following symptoms may occur: agitation, nausea, headache, and hot flashes.

In case of overdose patients should flush the stomach, take activated charcoal, consult a doctor. If necessary, symptomatic treatment is carried out.

.

Pregnancy use

Contraindicated in the first trimester of pregnancy and lactation, in the II and III trimesters of pregnancy can be used only with a doctor’s prescription.

Similarities

Troxerutin Vramed, Troxerutin Vetprom, Troxevasin, Troxerutin